Track Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's total liabilities ($46B) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest total liabilities for 600332.SS is $46B as of September 2026. That compares with $43B in the prior-year period — up 6.1% year over year. Investors often review this figure alongside Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's historical trend and sector peers before judging valuation or financial health.
Over the past year, 600332.SS's total liabilities moved from $43B to $46B — a 6.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's operating scale or balance-sheet position.
A total liabilities figure of $46B for 600332.SS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting 600332.SS's total liabilities ($46B), review year-over-year change from $43B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.